Skip to main content
Altimmune, Inc. (ALT)
NASDAQ: ALT · Real-Time Price · USD
2.740
-0.060 (-2.14%)
At close: Apr 28, 2026, 4:00 PM EDT
2.790
+0.049 (1.81%)
After-hours: Apr 28, 2026, 7:56 PM EDT

Altimmune Revenue

In the year 2025, Altimmune had annual revenue of $41.00K with 105.00% growth. Altimmune had revenue of $26.00K in the quarter ending December 31, 2025, with 420.00% growth.

Revenue (ttm)
$41.00K
Revenue Growth
+105.00%
P/S Ratio
12,978.20
Revenue / Employee
$719
Employees
57
Market Cap
532.11M

Revenue Chart

History

Fiscal Year End Revenue Change Growth
Dec 31, 202541.00K21.00K105.00%
Dec 31, 202420.00K-406.00K-95.31%
Dec 31, 2023426.00K494.00K-726.47%
Dec 31, 2022-68.00K-4.48M-101.54%
Dec 31, 20214.41M-3.78M-46.12%
Dec 31, 2020 Pro Pro Pro
Dec 31, 2019 Pro Pro Pro
Dec 31, 2018 Pro Pro Pro
Dec 31, 2017 Pro Pro Pro
Dec 31, 2016 Pro Pro Pro

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company Name Revenue
Rigel Pharmaceuticals 294.28M
Sutro Biopharma 102.48M
Fulcrum Therapeutics 80.00M
Adlai Nortye 5.00M
Ocugen 4.41M
ProKidney 893.00K
Lyell Immunopharma 36.00K
Revenue Rankings

ALT News

More News